Clovis Oncology Stock Rises On Patent Ruling For Ovarian Cancer Treatment – Investor’s Business Daily

Clovis Oncology Stock Rises On Patent Ruling For Ovarian Cancer Treatment  Investor’s Business Daily

Clovis Oncology stock jumped Tuesday after a European patent decision averted a “worst case” scenario for its ovarian cancer treatment, Rubraca.